dc.contributor.author | Yılmaz, Öznur | |
dc.contributor.author | ÖZTAY, FÜSÜN | |
dc.date.accessioned | 2021-03-03T15:56:30Z | |
dc.date.available | 2021-03-03T15:56:30Z | |
dc.identifier.citation | ÖZTAY F., Yılmaz Ö., "Dasatinib for use in the treatment, regression or decelerating the progress of fibrotic lung diseases", Diğer, ss.1-6, 2016 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_418cad44-4159-486d-9258-9655d3470085 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/47807 | |
dc.identifier.uri | http://google.com/patents/WO2016159917A1?cl=en&hl=tr | |
dc.description.abstract | The present invention relates to the use of dasatinib or its pharmaceutically acceptable salts thereof as a potential pharmaceutical agent, more preferably anti-proliferative or anti-fibrotic agent in fibrotic lung diseases, in particular idiopathic pulmoner fibrosis (IPF) disease. | |
dc.language.iso | eng | |
dc.subject | Tek Midelilerin Beslenmesi | |
dc.subject | Zootekni ve Hayvan Besleme | |
dc.subject | Yemler ve Hayvan Besleme | |
dc.subject | Ziraat | |
dc.subject | Tarımsal Bilimler | |
dc.subject | Biyoloji ve Biyokimya | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.title | Dasatinib for use in the treatment, regression or decelerating the progress of fibrotic lung diseases | |
dc.type | Diğer Yayınlar | |
dc.contributor.department | Diğer Kurumlar , , | |
dc.contributor.firstauthorID | 659163 | |